Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China-Biotics Reports Higher Revenues, Profits

publication date: Jun 21, 2007
Company Has 36% Profit Margin -- China-Biotics (Bulletin Board: CHBT) released its fourth quarter and full-year financial report. For the 2007 fiscal year, the company made a profit of $10.9 million on revenues of $30.6 million. Revenues were up 40% while the net income figure represents an increase of 31%. Earnings were a solid 36% of revenues. In China, China-Biotics operates through its wholly-owned subsidiary, Shanghai Shining Biotechnology Co. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here